Top Markets
#1 Audiera Audiera +33.84%
#2 TROLL TROLL +33.46%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.45%
#4 Bitcoin Cash Bitcoin Cash +32.20%
#5 GALA GALA +32.15%
#6 Fabric Protocol Fabric Protocol +31.41%
#7 B3 (Base) B3 (Base) +30.61%
#8 Tutorial Tutorial +28.97%
#9 Kamino Kamino +28.72%
#10 Bless Bless +28.27%
Coin of the day
Audiera Audiera
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rang in aandelen #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Aandeelprijs
$0.78611575
Marktkapitalisatie
$60.45M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-12.06%
Land
NO
Handel Lytix Biopharma AS (LYTIX)

Categorie

Healthcare
Aandelsplitsingen voor Lytix Biopharma AS (LYTIX)
Het aandeel Lytix Biopharma AS (symbool: LYTIX) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 21, 2026.
Eén aandeel LYTIX dat vóór Aug 21, 2026 werd gekocht, staat nu gelijk aan 0 aandelen LYTIX.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH